Arbutus Biopharma Corporation (ABUS)

[legalizeMJ]

TKMR PRICE TARGET = $1.0 to $3.0

I DO NOT THINK TKMR WILL RECOVER after a sell off

Because:

1) Once bitten, twice shy (investors won't come back).
2)TKMR has to go back to its drawing board and this will take
YEARS.
3) The FDA gave only VERBAL permit (Source: TKMR PR)
and FDA's permit is for the 2 Americans (which they are now better with ZMAPP)
4)The FDA didn't say anything about Ebola patients outside of the
U.S. (The FDA doesn't have any power there, only the W.H.O. does)

5) GSK is a better choice for W.H.O.
=============================
Please also read the 'Tonyeight' post #1084.
==================================